title: Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma.
authors.affiliation: Institute of Infection, Immunity & Inflammation, University of Glasgow and Respiratory Medicine, Glasgow, UK.
authors.forename: Neil C
authors.initials: NC
authors.lastname: Thomson
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D007073:Immunoglobulin E